BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 11071799)

  • 1. Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The TRACE Study Group.
    Gustafsson I; Hildebrandt P; Seibaek M; Melchior T; Torp-Pedersen C; Køber L; Kaiser-Nielsen P
    Eur Heart J; 2000 Dec; 21(23):1937-43. PubMed ID: 11071799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerating impact of diabetes mellitus on mortality in the years following an acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation.
    Melchior T; Kober L; Madsen CR; Seibaek M; Jensen GV; Hildebrandt P; Torp-Pedersen C
    Eur Heart J; 1999 Jul; 20(13):973-8. PubMed ID: 10361050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics, left and right ventricular ejection fraction, and long-term prognosis in patients with non-insulin-dependent diabetes surviving an acute myocardial infarction.
    Melchior T; Gadsbøll N; Hildebrandt P; Køber L; Torp-Pedersen C
    Diabet Med; 1996 May; 13(5):450-6. PubMed ID: 8737027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
    Meier JJ; Deifuss S; Klamann A; Schmiegel W; Nauck MA;
    Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction.
    Timmer JR; van der Horst IC; Ottervanger JP; Henriques JP; Hoorntje JC; de Boer MJ; Suryapranata H; Zijlstra F;
    Am Heart J; 2004 Sep; 148(3):399-404. PubMed ID: 15389225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acute ST-segment elevation myocardial infarction in West Pomerania province of Poland. Comparison between primary coronary intervention and thrombolytic therapy.
    Dryja T; Kornacewicz-Jach Z; Goracy J; Przybycień K; Jodko L; Skowronek A; Kurowski M; Zinka E
    Kardiol Pol; 2006 Jun; 64(6):591-9; discussion 600-1. PubMed ID: 16810577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial infarction in diabetics.
    Soler NG; Bennett MA; Pentecost BL; Fitzgerald MG; Malins JM
    Q J Med; 1975 Jan; 44(173):125-32. PubMed ID: 807945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of a history of diabetes on treatment and outcome in acute myocardial infarction, during two time periods and in two different countries.
    Svensson AM; Dellborg M; Abrahamsson P; Karlsson T; Herlitz J; Duval SJ; Berger AK; Luepker RV
    Int J Cardiol; 2007 Jul; 119(3):319-25. PubMed ID: 17067706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial.
    Timmer JR; Ottervanger JP; de Boer MJ; Boersma E; Grines CL; Westerhout CM; Simes RJ; Granger CB; Zijlstra F;
    Arch Intern Med; 2007 Jul; 167(13):1353-9. PubMed ID: 17620527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
    Aguilar D; Solomon SD; Køber L; Rouleau JL; Skali H; McMurray JJ; Francis GS; Henis M; O'Connor CM; Diaz R; Belenkov YN; Varshavsky S; Leimberger JD; Velazquez EJ; Califf RM; Pfeffer MA
    Circulation; 2004 Sep; 110(12):1572-8. PubMed ID: 15364810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does glucose level at hospital discharge predict one-year mortality in patients with diabetes mellitus treated with percutaneous coronary intervention for ST-segment elevation myocardial infarction?
    Gasior M; Pres D; Stasik-Pres G; Lech P; Gierlotka M; Lekston A; Hawranek M; Tajstra M; Kalarus Z; Poloński L
    Kardiol Pol; 2008 Jan; 66(1):1-8; discussion 9-11. PubMed ID: 18266182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of survival after successful percutaneous coronary intervention of patients with diabetes mellitus receiving insulin versus those receiving only diet and/or oral hypoglycemic agents.
    Mathew V; Frye RL; Lennon R; Barsness GW; Holmes DR
    Am J Cardiol; 2004 Feb; 93(4):399-403. PubMed ID: 14969610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes.
    McGuire DK; Newby LK; Bhapkar MV; Moliterno DJ; Hochman JS; Klein WW; Weaver WD; Pfisterer M; Corbalán R; Dellborg M; Granger CB; Van De Werf F; Topol EJ; Califf RM;
    Am Heart J; 2004 Feb; 147(2):246-52. PubMed ID: 14760321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.
    Mellbin LG; Malmberg K; Norhammar A; Wedel H; Rydén L;
    Eur Heart J; 2008 Jan; 29(2):166-76. PubMed ID: 18156614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction.
    Murcia AM; Hennekens CH; Lamas GA; Jiménez-Navarro M; Rouleau JL; Flaker GC; Goldman S; Skali H; Braunwald E; Pfeffer MA
    Arch Intern Med; 2004 Nov; 164(20):2273-9. PubMed ID: 15534166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QT-interval dispersion in type 2 diabetic and non-diabetic patients with post-myocardial infarction.
    Sakabe K; Fukuda N; Fukuda Y; Wakayama K; Nada T; Morishita S; Shinohara H; Tamura Y
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):121-6. PubMed ID: 17346952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival after myocardial infarction in diabetic patients. Part II. Hospital mortality in relation to the kind of hypoglycaemic treatment.
    Królewski AS; Janeczko D; Kobryń A; Puncewicz B
    Acta Med Pol; 1975; 16(1):53-9. PubMed ID: 1119327
    [No Abstract]   [Full Text] [Related]  

  • 19. Short and long-term outcome in diabetic patients with acute myocardial infarction in the invasive era.
    Hansen HH; Joensen AM; Riahi S; Malczynski J; Mølenberg D; Ravkilde J
    Scand Cardiovasc J; 2007 Jan; 41(1):19-24. PubMed ID: 17365973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of diabetes mellitus and its treatment on ventricular arrhythmias complicating acute myocardial infarction.
    Rana JS; Mukamal KJ; Nesto RW; Morgan JP; Muller JE; Mittleman MA
    Diabet Med; 2005 May; 22(5):576-82. PubMed ID: 15842512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.